LDX received FDA approval - "MELBOURNE, Australia (3 July 2023) – Lumos Diagnostics (ASX: LDX), (“Lumos” or the “Company”) a
leader in rapid, point-of-care (POC) diagnostic technologies, is pleased to announce that it has received
clearance from the US Food and Drug Administration (FDA) to market its FebriDx® rapid, point-of-care
test in the United States."
- Forums
- ASX - By Stock
- BOT
- BOT - Anything but charting
BOT - Anything but charting, page-6213
-
- There are more pages in this discussion • 3,809 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
39.0¢ |
Change
0.040(11.4%) |
Mkt cap ! $692.3M |
Open | High | Low | Value | Volume |
35.5¢ | 39.5¢ | 35.5¢ | $4.870M | 12.84M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 595036 | 38.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 734239 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 426424 | 0.385 |
11 | 832590 | 0.380 |
3 | 527400 | 0.375 |
5 | 213742 | 0.370 |
4 | 248239 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 847034 | 11 |
0.395 | 780068 | 27 |
0.400 | 1859975 | 34 |
0.405 | 840815 | 10 |
0.410 | 142681 | 13 |
Last trade - 15.28pm 30/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online